Influencing factors of anthracycline-induced subclinical cardiotoxicity in acute leukemia patients

Current treatment of acute leukemia is based on anthracycline chemotherapy. Anthracyclines, despite improving patient survival, have serious cardiotoxicity and therefore cardiac monitoring should be a priority.